Cardlytics Second Quarter 2026 Financial Results Driven By Strong Operational Performance
Cardlytics, Inc. (CDLX) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Cardlytics Second Quarter 2026 Financial Results Driven By Strong Operational Performance • Company delivers strong second quarter results: ◦ Revenues of $36.9 million ◦ Billings of $65.5 million ◦ Adjusted Contribution of $21.3 million ◦ Net Loss of $(14.9) million
How this was made
The 30-second read
Why it matters
Traders can update near-term expectations using the disclosed Q3 guidance bands and assess whether the margin improvement narrative offsets continued YoY declines in revenue, billings, users, and cash flow.
Market read
Fresh quarterly metrics plus explicit Q3 guidance create a tradable setup into and during the earnings webcast.
What to watch
MQUs fell 17% YoY and ACPU declined, so the key question is whether Q3 guidance implies stabilization in unit economics or continued top-line shrinkage.
Background
This is an SEC Form 8-K with Exhibit 99.1 covering Cardlytics’ Q2 2026 financial results and Q3 2026 guidance ranges.
Ticker impact
Cardlytics reported Q2 2026 results and provided Q3 2026 guidance ranges for Billings, Revenue, Adjusted Contribution, and Adjusted EBITDA.
Likely modest volatility around the earnings call and any market reaction to the guidance ranges versus expectations, with downside risk if investors focus on worsening net loss and cash burn.
The filing discloses fresh quarterly datapoints (revenue, billings, net loss, FCF) plus explicit Q3 guidance ranges, which can drive repricing even without a beat/raise narrative.
Market effects
Signals ongoing pressure on purchase-intelligence monetization (declining billings, users) while emphasizing margin improvement and self-sustainability efforts.
No specific regional read-through beyond US and UK platform operations mentioned.
Limited global impact; primarily a US-listed ad-tech/purchase-intelligence name with UK exposure.
Counterpoint
Investors may discount the “within guidance” framing and focus on worsening net loss, operating cash outflow, and free cash flow deterioration versus the prior year.
Key entities
- public_companyCardlytics, Inc.
Purchase intelligence platform reporting Q2 2026 results and issuing Q3 2026 guidance ranges.
- executiveAmit Gupta
CEO quoted on execution translating into results and being within guidance across key metrics.
- executiveDavid Evans
CFO quoted on sequential growth and self-sustainability plan.
